A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies-Reference-Cited by-同舟云学术

A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies

Published:2010-12-27 Issue:7 Volume:50 Page:1105-1110
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Gallerani Elisa,Bauer Jean,Hess Dagmar,Boehm Steffen,Droege Cornelia,Jeckelmann Sandrine,Miani Monica,Herrmann Richard,Marsoni Silvia,Sperka Sabine,Sessa Cristiana

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2010.543697

Reference17 articles.

1. Preclinical antitumor activity of the oral platinum analog satraplatin

2. Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer.

3. Phase II Study of Oral Platinum Drug JM216 as First-Line Treatment in Patients With Small-Cell Lung Cancer

4. Phase II study of cisplatin and 5‐fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185)

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRP: An energy-efficient routing protocol for underwater sensor networks;International Journal of Communication Systems;2017-02-28

2. Advances in oral delivery of anti-cancer prodrugs;Expert Opinion on Drug Delivery;2016-07-06

3. Monitoring the DNA by ruthenium complexes of heterocyclic N,S-donor ligands and evaluation of biological activities;Monatshefte für Chemie - Chemical Monthly;2016-03-10

4. Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects;Dalton Transactions;2016

5. Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy;Medicinal Research Reviews;2015-08-17